A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

Trial Profile

A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2016

At a glance

  • Drugs Eravacycline (Primary) ; Eravacycline (Primary) ; Levofloxacin; Levofloxacin
  • Indications Bacterial infections; Urinary tract infections
  • Focus Registrational; Therapeutic Use
  • Acronyms IGNITE 2
  • Sponsors Tetraphase Pharmaceuticals
  • Most Recent Events

    • 29 Nov 2016 According to a Tetraphase Pharmaceuticals media release, status changed from active, no longer recruiting to completed.
    • 27 May 2016 This study is completed in Hungary, Germany, Estonia, Czech Republic, Latvia, Bulgaria, Poland with end date as 2015-06-03 and Italy with End date as 2015-04-20 as per European Clinical Trials Database record.
    • 23 May 2016 Data will be presented at the American Society of Microbiology (ASM) Microbe 2016 Conference, as per Tetraphase Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top